Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
17 January 2017
Stansted Airport has made a bid to become Britain's next hub for long-haul travel, as passengers are promised seamless connection facilities and baggage transfer.
13 January 2017
Long-term goals such as travelling more and visiting new places have come above healthy eating and changing jobs in a list of the top New Year's resolutions.
14 January 2017
Some of the biggest airports in the UK have been forced to cancel flights as snow and blizzard conditions sweep parts of the country.
Stress could be as significant a risk factor for heart attacks and strokes as smoking, drinking and overeating, new research shows.
24 December 2016
Planned strikes by British Airways cabin crew on Christmas Day and Boxing Day have been suspended amid continuing industrial unrest ahead of the weekend break.
11 January 2017
A connection between diabetes and inflection in children could be a major breakthrough in developing a cure for type 1 diabetes, according to new research.
10 January 2017
A new trial aimed at tackling widespread loneliness among older people is successfully reducing isolation using community-based tactics, a report shows.
07 January 2017
People may be able to enjoy better brain health in later life by following a Mediterranean diet, research has suggested.
06 January 2017
Many Britons plan to cut down on the costs of their holidays in 2017, as part of their financial resolutions for the New Year.
05 January 2017
Holidaymakers have been encouraged to make the most of the fact 2017 boasts a pair of bank holiday weekends just two weeks apart.
04 January 2017
Holidaymakers are increasingly turning their attentions to trips which are all-inclusive, new research has suggested.
31 December 2016
Budget airline Norwegian has said it will launch ultra-low cost flights for as little at £56 to New York as it ramps up the pressure on its rivals.